XML 87 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of significant accounting policies - Narrative (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Aug. 23, 2023
May 08, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Segment
Employee
$ / shares
Jan. 01, 2023
USD ($)
$ / shares
Jan. 02, 2022
USD ($)
Dec. 29, 2019
Dec. 30, 2018
Jul. 02, 2023
USD ($)
Concentration of Credit Risk [Line Items]                
Number of employees | Employee     131,900          
Common Stock, Par or Stated Value Per Share | $ / shares     $ 1.00 $ 1.00        
Proceeds from Kenvue initial public offering     $ 4,241 $ 0 $ 0      
Realized gain (loss) on investment   $ 2,500            
Number of business segments | Segment     2          
Supplier finance program, obligation, current     $ 700 $ 700        
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]     Accounts Payable, Current Accounts Payable, Current        
Minimum reverse repurchase agreement collateral (as a percent)     102.00%          
Accrued rebates, returns and promotions     $ 16,001 $ 13,579        
Sales return reserve (as a percent)     1.00% 1.00% 1.00%      
Percentage of profit share payments (less than)     2.00% 3.00% 3.00%      
Cost of products sold     $ 26,553 $ 24,596 $ 23,402      
Shipping and handling costs as a percent of sales     1.00% 1.00% 1.00%      
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]     Other assets, noncurrent Other assets, noncurrent        
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]     Accrued Liabilities, Current Accrued Liabilities, Current        
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]     Other Liabilities, Noncurrent Other Liabilities, Noncurrent        
Operating lease, right-of-use asset     $ 1,000          
Operating lease liabilities     1,100          
Operating lease costs     200 $ 200 $ 200      
Cash paid for operating leases     200 200 200      
Advertising expense     $ 500 $ 700 $ 1,200      
U.S. statutory rate     21.00% 21.00% 21.00% 21.00% 35.00%  
TCJA, undistributed foreign earnings percent related to cash and cash equivalents           15.50%    
TCJA, undistributed foreign earnings percent related to earnings other than cash and cash equivalents           8.00%    
TCJA, provisional liability     $ 4,500          
TJCA , provisional liability, non-current     2,500          
Repatriation of foreign earnings amount     500          
Selling, marketing and administrative expenses     $ 21,512 $ 20,246 $ 20,118      
Kenvue Inc.                
Concentration of Credit Risk [Line Items]                
Split-off percentage 80.10%              
Kenvue Inc.                
Concentration of Credit Risk [Line Items]                
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.01            
Sale of stock (in USD per share) | $ / shares   $ 22.00            
Johnson & Johnson | Kenvue Inc.                
Concentration of Credit Risk [Line Items]                
Percentage ownership after transaction   89.60%            
Common stock, value               $ 1,300
Percentage ownership after transaction 9.50%              
IPO | Kenvue Inc.                
Concentration of Credit Risk [Line Items]                
Sale of stock, number of shares issued in transaction (in shares) | shares   198,734,444            
Proceeds from Kenvue initial public offering   $ 4,200            
Minimum | Software Development                
Concentration of Credit Risk [Line Items]                
Estimated useful lives of the assets     3 years          
Maximum | Software Development                
Concentration of Credit Risk [Line Items]                
Estimated useful lives of the assets     8 years          
R&D Expense | Project Concentration Risk                
Concentration of Credit Risk [Line Items]                
Concentration risk, threshold percentage (as a percent)     0.05 0.05 0.05      
Shipping and Handling                
Concentration of Credit Risk [Line Items]                
Cost of products sold       $ 800 $ 800      
Selling, marketing and administrative expenses     $ 900          
Pharmaceutical                
Concentration of Credit Risk [Line Items]                
Accrued rebates, returns and promotions     $ 11,500 $ 9,600